Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging

Bibliographic Details
Main Authors: Calin Nicolescu, Andrew Schilb, Jiyoon Kim, Da Sun, Ryan Hall, Songqi Gao, Hannah Gilmore, William P. Schiemann, Zheng-Rong Lu
Format: Article
Language:English
Published: American Chemical Society 2023-03-01
Series:Chemical & Biomedical Imaging
Online Access:https://doi.org/10.1021/cbmi.3c00011
_version_ 1797736142903181312
author Calin Nicolescu
Andrew Schilb
Jiyoon Kim
Da Sun
Ryan Hall
Songqi Gao
Hannah Gilmore
William P. Schiemann
Zheng-Rong Lu
author_facet Calin Nicolescu
Andrew Schilb
Jiyoon Kim
Da Sun
Ryan Hall
Songqi Gao
Hannah Gilmore
William P. Schiemann
Zheng-Rong Lu
author_sort Calin Nicolescu
collection DOAJ
first_indexed 2024-03-12T13:09:19Z
format Article
id doaj.art-6a570d95a9cd4f3e8d6fd6def1bf3aa1
institution Directory Open Access Journal
issn 2832-3637
language English
last_indexed 2024-03-12T13:09:19Z
publishDate 2023-03-01
publisher American Chemical Society
record_format Article
series Chemical & Biomedical Imaging
spelling doaj.art-6a570d95a9cd4f3e8d6fd6def1bf3aa12023-08-28T07:14:36ZengAmerican Chemical SocietyChemical & Biomedical Imaging2832-36372023-03-011546147010.1021/cbmi.3c00011Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular ImagingCalin Nicolescu0Andrew Schilb1Jiyoon Kim2Da Sun3Ryan Hall4Songqi Gao5Hannah Gilmore6William P. Schiemann7Zheng-Rong Lu8Department of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United StatesDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United StatesDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United StatesDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United StatesDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United StatesDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United StatesDepartment of Pathology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio, United StatesCase Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio, United StatesDepartment of Biomedical Engineering, Case Western Reserve University, Cleveland, Ohio, United Stateshttps://doi.org/10.1021/cbmi.3c00011
spellingShingle Calin Nicolescu
Andrew Schilb
Jiyoon Kim
Da Sun
Ryan Hall
Songqi Gao
Hannah Gilmore
William P. Schiemann
Zheng-Rong Lu
Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging
Chemical & Biomedical Imaging
title Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging
title_full Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging
title_fullStr Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging
title_full_unstemmed Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging
title_short Evaluating Dual-Targeted ECO/siRNA Nanoparticles against an Oncogenic lncRNA for Triple Negative Breast Cancer Therapy with Magnetic Resonance Molecular Imaging
title_sort evaluating dual targeted eco sirna nanoparticles against an oncogenic lncrna for triple negative breast cancer therapy with magnetic resonance molecular imaging
url https://doi.org/10.1021/cbmi.3c00011
work_keys_str_mv AT calinnicolescu evaluatingdualtargetedecosirnananoparticlesagainstanoncogeniclncrnafortriplenegativebreastcancertherapywithmagneticresonancemolecularimaging
AT andrewschilb evaluatingdualtargetedecosirnananoparticlesagainstanoncogeniclncrnafortriplenegativebreastcancertherapywithmagneticresonancemolecularimaging
AT jiyoonkim evaluatingdualtargetedecosirnananoparticlesagainstanoncogeniclncrnafortriplenegativebreastcancertherapywithmagneticresonancemolecularimaging
AT dasun evaluatingdualtargetedecosirnananoparticlesagainstanoncogeniclncrnafortriplenegativebreastcancertherapywithmagneticresonancemolecularimaging
AT ryanhall evaluatingdualtargetedecosirnananoparticlesagainstanoncogeniclncrnafortriplenegativebreastcancertherapywithmagneticresonancemolecularimaging
AT songqigao evaluatingdualtargetedecosirnananoparticlesagainstanoncogeniclncrnafortriplenegativebreastcancertherapywithmagneticresonancemolecularimaging
AT hannahgilmore evaluatingdualtargetedecosirnananoparticlesagainstanoncogeniclncrnafortriplenegativebreastcancertherapywithmagneticresonancemolecularimaging
AT williampschiemann evaluatingdualtargetedecosirnananoparticlesagainstanoncogeniclncrnafortriplenegativebreastcancertherapywithmagneticresonancemolecularimaging
AT zhengronglu evaluatingdualtargetedecosirnananoparticlesagainstanoncogeniclncrnafortriplenegativebreastcancertherapywithmagneticresonancemolecularimaging